BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38151690)

  • 21. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
    JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suicide rates among patients with first and second primary cancer.
    Jiang Y; Wang Y; Cheng X; Zhou Z; Wang J; Yu H; Yao G; Lu Z; Chen X; Yan S; Zhao F
    Epidemiol Psychiatr Sci; 2023 Sep; 32():e57. PubMed ID: 37711033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second primary cancer among 217702 colorectal cancer survivors: An analysis of national German cancer registry data.
    Liang LA; Tseng YJ; Tanaka LF; Klug SJ
    Int J Cancer; 2023 Oct; 153(8):1459-1471. PubMed ID: 37392091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant risk of second primary cancer among laryngeal squamous cell carcinoma patients even after 20 years.
    Nikkilä R; Hirvonen E; Haapaniemi A; Tapiovaara L; Pitkäniemi J; Malila N; Mäkitie A
    Acta Oncol; 2023 Oct; 62(10):1322-1330. PubMed ID: 37672344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.
    Heudel P; Chabaud S; Perol D; Flechon A; Fayette J; Combemale P; Tredan O; Desseigne F; de la Fouchardiere C; Boyle H; Perol M; Bachelot T; Cassier P; Avrillon V; Terret C; Michallet AS; Neidhardt-Berard EM; Nicolas-Virelizier E; Dufresne A; Belhabri A; Brahmi M; Lebras L; Nicolini F; Sarabi M; Rey P; Bonneville-Levard A; Rochefort P; Provensal AM; Eberst L; Assaad S; Swalduz A; Saintigny P; Toussaint P; Guillermin Y; Castets M; Coutzac C; Meeus P; Dupré A; Durand T; Crochet H; Fervers B; Gomez F; Rivoire M; Gregoire V; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Lasset C; Chvetzoff G; Mehlen P; Beaupère S; Zrounba P; Ray-Coquard I; Blay JY
    ESMO Open; 2021 Feb; 6(1):100044. PubMed ID: 33516148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
    Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High incidence combination of multiple primary malignant tumors of the digestive system.
    Yang XB; Zhang LH; Xue JN; Wang YC; Yang X; Zhang N; Liu D; Wang YY; Xun ZY; Li YR; Sun HS; Zhao LJ; Zhao HT
    World J Gastroenterol; 2022 Nov; 28(41):5982-5992. PubMed ID: 36405110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal trends in competing mortality from second and subsequent primary cancers, 1980-2014: An Australian population-based study.
    Ye Y; Otahal P; Wills KE; Neil AL; Venn AJ
    Cancer Epidemiol; 2018 Aug; 55():61-67. PubMed ID: 29803142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.
    Vuolukka K; Auvinen P; Palmgren JE; Aaltomaa S; Kataja V
    BMC Cancer; 2020 May; 20(1):453. PubMed ID: 32434560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
    Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
    Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers.
    Sung H; Siegel RL; Hyun N; Miller KD; Yabroff KR; Jemal A
    J Natl Cancer Inst; 2022 Aug; 114(8):1095-1108. PubMed ID: 35511931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.
    Feller A; Matthes KL; Bordoni A; Bouchardy C; Bulliard JL; Herrmann C; Konzelmann I; Maspoli M; Mousavi M; Rohrmann S; Staehelin K; Arndt V;
    BMC Cancer; 2020 Jan; 20(1):51. PubMed ID: 31964352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic implications of bilateral breast cancer: a population based cohort study.
    Hartman M; Czene K; Reilly M; Bergh J; Lagiou P; Trichopoulos D; Adami HO; Hall P
    Lancet Oncol; 2005 Jun; 6(6):377-82. PubMed ID: 15925815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US.
    Sung H; Nisotel L; Sedeta E; Islami F; Jemal A
    JAMA Netw Open; 2023 Aug; 6(8):e2327429. PubMed ID: 37540510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor.
    Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
    Cancer Med; 2020 Nov; 9(21):8258-8265. PubMed ID: 32960498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer Prevention for Survivors: Incidence of Second Primary Cancers and Sex Differences-A Population-Based Study from an Italian Cancer Registry.
    Ragusa R; Torrisi A; Di Prima AA; Torrisi AA; Ippolito A; Ferrante M; Madeddu A; Guardabasso V
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors.
    Bailey S; Ezratty C; Mhango G; Lin JJ
    Breast Cancer; 2023 Mar; 30(2):215-225. PubMed ID: 36316601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.
    Adjei Boakye E; Wang M; Sharma A; Jenkins WD; Osazuwa-Peters N; Chen B; Lee M; Schootman M
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1765-1779. PubMed ID: 32356175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.
    Liu H; Hemminki K; Sundquist J; Holleczek B; Katalinic A; Emrich K; Jansen L; Brenner H;
    Cancer Med; 2013 Oct; 2(5):718-24. PubMed ID: 24403237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.